ChartMill · Sep 23, 2026
Stay updated with the stocks that are on the move in today's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
AR
NASDAQ · ARTL
Artelo Biosciences, Inc.
Healthcare · Biotechnology
$3.37
Down-$0.11 (-3.26%)
Updated Oct 9, 2026, 10:20 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.75M
- P/E ratio
- -0.1
- Dividend yield
- 0.00%
- 52-week range
- $0.66 – $19.91
- Volume
- 27.35K
- Avg. volume
- 491.32K
Price performance · ARTL
ARTL price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
ARTL closed at $3.37 after 21 trading sessions, down 40.14% for the selected period.
- Last close
- $3.37
- Period change
- -40.14%
- Period low
- $3.37
- Period high
- $7.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $3.51 | $3.51 | $3.37 | $3.37 | 27.35K |
| Oct 7, 2026 | $3.42 | $3.55 | $3.33 | $3.41 | 52.25K |
| Oct 6, 2026 | $3.65 | $3.74 | $3.41 | $3.46 | 74.66K |
| Oct 5, 2026 | $3.75 | $3.75 | $3.50 | $3.51 | 53.38K |
| Oct 2, 2026 | $3.8501 | $3.8501 | $3.63 | $3.68 | 63.8K |
| Oct 1, 2026 | $4.04 | $4.07 | $3.80 | $3.83 | 93.02K |
| Sep 30, 2026 | $4.06 | $4.30 | $3.9501 | $4.04 | 68.5K |
| Sep 29, 2026 | $4.20 | $4.30 | $4.05 | $4.07 | 88.96K |
| Sep 28, 2026 | $4.44 | $4.55 | $4.25 | $4.30 | 157.03K |
| Sep 25, 2026 | $4.93 | $4.93 | $4.43 | $4.54 | 260.25K |
| Sep 24, 2026 | $4.87 | $5.35 | $4.51 | $5.17 | 1.06M |
| Sep 23, 2026 | $4.03 | $15.73 | $3.90 | $7.31 | 25.13M |
| Sep 22, 2026 | $4.14 | $4.20 | $3.86 | $4.15 | 324.28K |
| Sep 21, 2026 | $3.89 | $4.19 | $3.8821 | $4.10 | 73.08K |
| Sep 18, 2026 | $4.00 | $4.1358 | $3.92 | $3.94 | 29.66K |
| Sep 17, 2026 | $3.84 | $4.0199 | $3.69 | $3.97 | 125.24K |
| Sep 16, 2026 | $4.90 | $4.90 | $3.45 | $3.75 | 277.96K |
| Sep 15, 2026 | $4.88 | $5.6499 | $4.88 | $5.34 | 91.46K |
| Sep 14, 2026 | $5.28 | $5.49 | $4.86 | $4.87 | 54.92K |
| Sep 11, 2026 | $5.69 | $5.84 | $5.35 | $5.43 | 41.93K |
| Sep 10, 2026 | $5.89 | $6.00 | $5.6101 | $5.63 | 43.51K |
Latest ARTL news
The latest Smart Investors Daily articles mentioning ARTL.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ARTL research
Overview
Company profile and research snapshot.
Company profile
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 19, 2025 | Maxim Group | Hold | — |
| Sep 8, 2025 | D. Boral Capital | Hold | — |
| Aug 26, 2025 | D. Boral Capital | Buy | — |
| Aug 18, 2025 | D. Boral Capital | Buy | — |
| Aug 6, 2025 | D. Boral Capital | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 23, 2026
Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening?
Artelo Biosciences, Inc. (NASDAQ: ARTL) shares are surging Wednesday afternoon after the clinical-stage biopharmaceutical company announced the filing of a new provisional patent application covering its drug candidate ART27.13 for the treatment of obesity.
Benzinga · Sep 23, 2026
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regular session. The market value of their outstanding shares is at $2.2 million. Vistagen Therapeutics (NASDAQ:VTGN) shares
Yahoo · Sep 23, 2026
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
As reported, ART27.13 produced approximately 40% weight loss in combination with semaglutide and approximately 20% as monotherapy, comparable to semaglutide, in obese mice over four weeks Application expands Artelo’s intellectual property position for ART27.13 into obesity, where J.P. Morgan has projected the global GLP-1 market could reach $200 billion by 2030 New findings show the combination further improved oral glucose tolerance and increased bone mineral density, an effect not observed in
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
